Custom Biologics is a global leader in bioanalytical contract research organization (CRO) services, specializing in the development, validation, and testing of assays for biopharmaceutical drug development. With over 20 years of experience, the company provides GLP-compliant services that support pre-clinical and clinical stages, focusing on functional characterization, potency assessments, and immunogenicity studies. Their proprietary DASL-Rapid technology enhances genomic analysis, making them a trusted partner for biopharmaceutical companies worldwide. Custom Biologics maintains a rigorous quality system and has conducted over 200 studies for more than 125 clients, positioning itself as a reliable player in the biopharmaceutical testing market.
Something looks off?